Modus Therapeutics Stock Forecast - 4 Period Moving Average
| MODTX Stock | 0.31 0.01 3.33% |
The 4 Period Moving Average forecasted value of Modus Therapeutics Holding on the next trading day is expected to be 0.30 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 0.86. Modus Stock Forecast is based on your current time horizon.
At this time, The value of RSI of Modus Therapeutics' share price is at 50. This indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Modus Therapeutics, making its price go up or down. Momentum 50
Impartial
Oversold | Overbought |
Using Modus Therapeutics hype-based prediction, you can estimate the value of Modus Therapeutics Holding from the perspective of Modus Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The 4 Period Moving Average forecasted value of Modus Therapeutics Holding on the next trading day is expected to be 0.30 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 0.86. Modus Therapeutics after-hype prediction price | SEK 0.31 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Modus |
Modus Therapeutics Additional Predictive Modules
Most predictive techniques to examine Modus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Modus using various technical indicators. When you analyze Modus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Modus Therapeutics 4 Period Moving Average Price Forecast For the 7th of January
Given 90 days horizon, the 4 Period Moving Average forecasted value of Modus Therapeutics Holding on the next trading day is expected to be 0.30 with a mean absolute deviation of 0.02, mean absolute percentage error of 0.0003, and the sum of the absolute errors of 0.86.Please note that although there have been many attempts to predict Modus Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Modus Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Modus Therapeutics Stock Forecast Pattern
| Backtest Modus Therapeutics | Modus Therapeutics Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Modus Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Modus Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 102.7757 |
| Bias | Arithmetic mean of the errors | 0.0065 |
| MAD | Mean absolute deviation | 0.015 |
| MAPE | Mean absolute percentage error | 0.0405 |
| SAE | Sum of the absolute errors | 0.8575 |
Predictive Modules for Modus Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Modus Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Modus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Modus Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Modus Therapeutics stock to make a market-neutral strategy. Peer analysis of Modus Therapeutics could also be used in its relative valuation, which is a method of valuing Modus Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Modus Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Modus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Modus Therapeutics shares will generate the highest return on investment. By undertsting and applying Modus Therapeutics stock market strength indicators, traders can identify Modus Therapeutics Holding entry and exit signals to maximize returns.
Modus Therapeutics Risk Indicators
The analysis of Modus Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Modus Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting modus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.56 | |||
| Standard Deviation | 4.48 | |||
| Variance | 20.04 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Modus Stock Analysis
When running Modus Therapeutics' price analysis, check to measure Modus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Modus Therapeutics is operating at the current time. Most of Modus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Modus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Modus Therapeutics' price. Additionally, you may evaluate how the addition of Modus Therapeutics to your portfolios can decrease your overall portfolio volatility.